World Journal of Endocrine Surgery

Register      Login

VOLUME 13 , ISSUE 2 ( May-August, 2021 ) > List of Articles

CASE REPORT

A Rare Case of Bilateral Pheochromocytoma

Senthil K Azhisoor Chandrashekhar, Pallavi B Kothe, Muthuvel G Esakki, Rajalakshmi K Venkatraju, Priya D Venugopalan

Citation Information : Azhisoor Chandrashekhar SK, Kothe PB, Esakki MG, Venkatraju RK, Venugopalan PD. A Rare Case of Bilateral Pheochromocytoma. World J Endoc Surg 2021; 13 (2):57-60.

DOI: 10.5005/jp-journals-10002-1400

License: CC BY-NC 4.0

Published Online: 31-01-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Pheochromocytoma is a rare adrenal gland tumor, which can present bilaterally but not all cases have indications of bilateral adrenalectomy. Hereby presenting a case of a young girl of bilateral adrenal pheochromocytoma for which bilateral adrenalectomy (right side cortical sparing) was done. Correct diagnosis and timely intervention are important to prevent lifelong complications.


HTML PDF Share
  1. Giford RW, Jr, Kvale WF, Maher FT, et al. Clinical features, diagnosis and treatment of pheochromocytoma: A review of 76 cases. Mayo Clin Proc 1964;39:281–302.
  2. Neumann HPH, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459–1466. DOI: 10.1056/NEJMoa020152
  3. Sawka AM, Prebtani AP, Tabane L, et al. A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocr Disord 2004;4:2. DOI: 10.1186/1472-6823-4-2a
  4. Perry CG, Sawka AM, Singh R, et al. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol (Oxf) 2007;66:703–708. DOI: 10.1111/j.1365-2265.2007.02805.x
  5. Timmers HJ, Chen CC, Carrasquillo JA, et al. Comparison of 18F-fuoro-L-DOPA, 18F-fuoro-deoxyglucose, and 18F-fuorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 200994:4757–4767. DOI: 10.1210/jc.2009-1248
  6. Kinney MAO, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 2002;16:359–369. DOI: 10.1053/jcan.2002.124150
  7. Brunaud L, Boutami M, Nguyen-Thi PL, et al. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery 2014;156(6):1410–1417. DOI: 10.1016/j.surg.2014.08.022
  8. Shen WT, Grogan R, Vriens M, et al. One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy. Arch Surg 2010;145:893–897. DOI: 10.1001/archsurg.2010.159
  9. Shen WT, Sturgeon C, Clark OH, et al. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas. Surgery 2004;136(6):1129–1137. DOI: 10.1016/j.surg.2004.05.058
  10. Anouk S. Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Ann Surg 2011;254(6):1022–1027. DOI: 10.1097/SLA.0b013e318237480c
  11. Gonias S, Goldsby R, Matthay KK, et al. Phase II study of high-dose [131I] metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol 2009;27:4162–4168. DOI: 10.1200/JCO.2008.21.3496
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.